4
Changes in Ownership
Emergent BioSolutions Inc. Filed Acc 0001367644-22-000042
EVP, Chief Financial Officer gave up 818 shares (to pay taxes)
- EVP, Chief Financial Officer acquired 48,333 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
LINDAHL RICHARD S · EVP, Chief Financial Officer
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-03-01 | Grant or award : show line 1 in the form | +31,417 | 69,375 | D | ||
| 2022-03-01 | Grant or award : show line 2 in the form | +16,916 | 86,291 | D | ||
| 2022-02-28 | Shares withheld for taxes : show line 3 in the form | −818 | $39.64 | $32,426 | 85,473 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-03-01 | Grant or award : show line 4 in the form Employee Stock Options (Right to Buy) | +38,664 | $41.38 | $1,599,916 | 38,664 | D |
Loading xslF345X03/wf-form4_164626472010733.xml…